Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Clovis Oncology, Inc. (CLVSQ) vs Tempest Therapeutics, Inc. (TPST)

Clovis Oncology, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Tempest Therapeutics, Inc. are of similar size ($14.4M and $14.2M). Clovis Oncology, Inc. grew revenue faster over the last twelve months: −14.8% against −53.0%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −189.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Clovis Oncology, Inc. leads on 8 and Tempest Therapeutics, Inc. on 7.

Valuation

Metric CLVSQ TPST Biotechnology median
P/E n/m n/m 7.88
P/S 0.10 39.00 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.08 52.83 10.73
Earnings yield (2,033.33%) (515.66%) (28.84%)
Free cash flow yield (1,412.40%) (167.50%) (23.03%)

Profitability

Metric CLVSQ TPST Biotechnology median
Gross margin 72.21% 0.00% 65.16%
Operating margin (155.38%) 0.00% 0.00%
Net margin (189.37%) 0.00% 0.00%
Free cash flow margin (132.19%) 0.00% 0.00%
Return on equity 78.31% (931.14%) (57.72%)
Return on assets (58.94%) (237.25%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLVSQ TPST Biotechnology median
Revenue growth (TTM) (14.78%) (52.98%) 5.64%
EPS growth (last fiscal year) 47.72% 67.55% —
Revenue growth, 5-year CAGR 352.98% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVSQ TPST Biotechnology median
Debt to equity (1.09) 0.00 0.00
Current ratio 0.14 0.38 4.73
Net debt to EBITDA (2.21) 0.29 0.96

Dividend

Metric CLVSQ TPST Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLVSQ TPST Biotechnology median
Market cap 14.23m 14.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack